Enorama Pharma AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ERMA.ST research report →
Companywww.enorama.se
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.
- CEO
- Bengt Jönsson
- IPO
- 2016
- Employees
- 5
- HQ
- Malmö, SE
Price Chart
Valuation
- Market Cap
- $24.02M
- P/E
- -0.32
- P/S
- 8.77
- P/B
- -1.02
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1490.03%
- Op Margin
- -2284.30%
- Net Margin
- -2743.30%
- ROE
- 2854.01%
- ROIC
- 266.80%
Growth & Income
- Revenue
- $2.74M · -82.63%
- Net Income
- $-75,139,000 · -71.53%
- EPS
- $-1.08 · -30.12%
- Op Income
- $-62,120,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $3.58
- 52W Low
- $0.21
- 50D MA
- $0.35
- 200D MA
- $1.70
- Beta
- 1.60
- Avg Volume
- 58.15K
Get TickerSpark's AI analysis on ERMA.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ERMA.ST Coverage
We haven't published any research on ERMA.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ERMA.ST Report →